FDA Requires Multiple Reports On New Accutane Risk Management Program

FDA is requiring manufacturers of the acne therapy isotretinoin (Roche's Accutane and generics) to submit multiple reports to the agency on the effectiveness of the product's new risk management program iPLEDGE